Level 9, 365 Little Collins Street, Melbourne, Victoria, 3000

Paradigm: A company with massive near-term potential

In my time at University (which seems like a lifetime ago) I recall two types of lecturers: Those that guided the students towards what to expect at exam time, and those that didn’t.

Unsurprisingly, there was a strong correlation between the type of lecturer, the student attendance late in the term, and the pass rate. Once students knew what to expect in an exam and where to find the answers, it would take a special kind of person to fail.

Management at Paradigm Biopharmaceuticals are the type of people that, had they been lecturers at University, would have had near 100% attendance in the final weeks of class, and a near 100% pass rate.

Click here to read the full article in Livewire.

Share the Post:

Related Posts

Access the Global Fund webinar slides

Access the complete presentation deck with portfolio insights and investment examples

Access the Global Fund Fact Sheet

Get instant online access to key fund features, metrics and performance

Access the Global Fund Information Memorandum

Get instant online access to complete fund details, investment strategy, and terms

Download the Information Memorandum

Download the White Paper

We anticipated the strong uranium market in 2017. Gold in 2019. Gold again in 2023. Find out what we think is next.

Download the latest investor presentation

Watch the ausbiz interview